This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2009 Dec 15;73(24):2127-9.

doi: 10.1212/WNL.0b013e3181c679df.

Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment

H Cario¹, H Bode, K-M Debatin, T Opladen, K Schwarz

Affiliations

PMID: 20018644
DOI: 10.1212/WNL.0b013e3181c679df

Case Reports

Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment

H Cario et al. Neurology. 2009.

. 2009 Dec 15;73(24):2127-9.

doi: 10.1212/WNL.0b013e3181c679df.

Authors

H Cario¹, H Bode, K-M Debatin, T Opladen, K Schwarz

Affiliation

¹ Department of Pediatrics and Adolescent Medicine, University Hospital Ulm, Eythstrasse 24, D-89075 Ulm, Germany. holger.cario@uniklinik-ulm.de

PMID: 20018644
DOI: 10.1212/WNL.0b013e3181c679df

No abstract available

PubMed Disclaimer

Similar articles

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution.
Ramaekers VT, Häusler M, Opladen T, Heimann G, Blau N. Ramaekers VT, et al. Neuropediatrics. 2002 Dec;33(6):301-8. doi: 10.1055/s-2002-37082. Neuropediatrics. 2002. PMID: 12571785
Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism.
Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, Wevers R, Grosso S, Gärtner J. Steinfeld R, et al. Am J Hum Genet. 2009 Sep;85(3):354-63. doi: 10.1016/j.ajhg.2009.08.005. Am J Hum Genet. 2009. PMID: 19732866 Free PMC article.
Novel mutations in the 5'-UTR of the FOLR1 gene.
Börjel AK, Yngve A, Sjöström M, Nilsson TK. Börjel AK, et al. Clin Chem Lab Med. 2006;44(2):161-7. doi: 10.1515/CCLM.2006.029. Clin Chem Lab Med. 2006. PMID: 16475900
The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?
Kelemen LE. Kelemen LE. Int J Cancer. 2006 Jul 15;119(2):243-50. doi: 10.1002/ijc.21712. Int J Cancer. 2006. PMID: 16453285 Review.
Cerebral folate deficiency.
Hyland K, Shoffner J, Heales SJ. Hyland K, et al. J Inherit Metab Dis. 2010 Oct;33(5):563-70. doi: 10.1007/s10545-010-9159-6. Epub 2010 Jul 29. J Inherit Metab Dis. 2010. PMID: 20668945 Review.

See all similar articles

Cited by

Update and new concepts in vitamin responsive disorders of folate transport and metabolism.
Watkins D, Rosenblatt DS. Watkins D, et al. J Inherit Metab Dis. 2012 Jul;35(4):665-70. doi: 10.1007/s10545-011-9418-1. Epub 2011 Nov 23. J Inherit Metab Dis. 2012. PMID: 22108709 Review.
Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.
Zhao R, Visentin M, Goldman ID. Zhao R, et al. Cancer Chemother Pharmacol. 2015 Jun;75(6):1163-73. doi: 10.1007/s00280-015-2733-8. Epub 2015 Apr 7. Cancer Chemother Pharmacol. 2015. PMID: 25847479 Free PMC article.
Functional regulation of P-glycoprotein at the blood-brain barrier in proton-coupled folate transporter (PCFT) mutant mice.
Wang X, Cabrera RM, Li Y, Miller DS, Finnell RH. Wang X, et al. FASEB J. 2013 Mar;27(3):1167-75. doi: 10.1096/fj.12-218495. Epub 2012 Dec 4. FASEB J. 2013. PMID: 23212123 Free PMC article.
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.
Zhao R, Goldman ID. Zhao R, et al. Mol Aspects Med. 2013 Apr-Jun;34(2-3):373-85. doi: 10.1016/j.mam.2012.07.006. Mol Aspects Med. 2013. PMID: 23506878 Free PMC article. Review.
Treatable Genetic Metabolic Epilepsies.
Assi L, Saklawi Y, Karam PE, Obeid M. Assi L, et al. Curr Treat Options Neurol. 2017 Sep;19(9):30. doi: 10.1007/s11940-017-0467-0. Curr Treat Options Neurol. 2017. PMID: 28741119 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information